Trading a NVCT straddle lets you take a pure volatility position on Nuvectis Pharma Inc without committing to a direction. Nuvectis Pharma Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate NVCT straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on NVCT profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Nuvectis Pharma Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the NVCT straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the NVCT straddle is the cleanest expression of that view. Our scanner prices every NVCT straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a NVCT straddle into a catalyst or short a NVCT straddle to harvest decay, the options straddle setups that matter are all in one place.
